FM
Fady Ibraham Malik (EVP Research & Development) filed 19 Form 4 reports in the trailing twelve months (0 purchases, 19 sales), most often in Cytokinetics, Incorporated (CYTK). The largest single filing was $748K of CYTK (12,033 sh across 2 lots, as filed), executed Mar 17. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
19
0 buys · 19 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$4.7M
shares × price, as filed
Last traded
Nov 3
Filed Nov 3
Median ADV $207.8M across their filed names
Open performance→Volume by month
Buys $0
Sells $6.4M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
19 filings
Sector per market data · by filing · past 12 months
Most traded names
CYTKRecent filings
CYTKSALE
Cytokinetics, Incorporated
View filing →
$278K3,500 sh × $79.51
Exec Jun 23
Filed Jun 23 · 5:30 PM ET CYTKSALE Cytokinetics, Incorporated View filing → $238K
3,500 sh × $67.98
Exec Jun 9
Filed Jun 9 · 5:30 PM ET CYTKSALE Cytokinetics, Incorporated View filing → $265K
3,500 sh × $75.69
Exec May 19
Filed May 20 · 5:30 PM ET CYTKSALE Cytokinetics, Incorporated View filing → $271K
3,500 sh × $77.37
Exec May 5
Filed May 5 · 5:30 PM ET CYTKSALE Cytokinetics, Incorporated View filing → $230K
3,500 sh × $65.69
Exec Apr 21
Filed Apr 21 · 5:30 PM ET CYTKSALE Cytokinetics, Incorporated View filing → $228K
3,500 sh × $65.21
Exec Apr 7
Filed Apr 8 · 5:30 PM ET CYTKSALE Cytokinetics, Incorporated View filing → $748K
12,033 sh across 2 lots
Exec Mar 17
Filed Mar 18 · 5:30 PM ET CYTKSALE Cytokinetics, Incorporated View filing → $177K
2,907 sh × $60.72
Exec Mar 9
Filed Mar 10 · 5:30 PM ET More filings →